The two jurisdictions ask different questions. Canadian endoscope reprocessing leans on a national standard for reprocessing of reusable medical devices together with provincial health authority policy, and on the device manufacturer's validated instructions; the US leans on federal device clearance plus CDC and professional-society guidance, with state rules layered on top. For a facility that operates on both sides of the border, or a supplier that ships to both, the practical difference is documentation: Canada asks you to show the reprocessing method you followed and its record, while the US asks you to show the cleared labelling and the high-level disinfection or sterilization process for that device. Canadian facilities typically stock the consumables that support the cycle, such as Class 4 dual-indicator pouches for the instruments around the scope and an ultrasonic cleaner for the instrument pre-clean step.
Below is a side-by-side comparison of the two frameworks, then the questions a clinic should answer before writing its reprocessing policy.
Canada vs the US: which requirements apply to endoscope reprocessing?
| Item | Canada | United States |
|---|---|---|
| Primary framework | National reusable-device reprocessing standard plus provincial health authority policy | Federal device authorisation plus CDC guidance and professional society standards |
| Device authorisation | Manufacturer labelling accepted on the Canadian market | Premarket notification, commonly called a 510(k) for this device class |
| High-level disinfection | Follow the method the manufacturer validated | Follow the cleared labelling; society guidance adds detail |
| Record kept | Reprocessing record per scope, per cycle, with the chemical used | Reprocessing record plus device traceability to the patient |
| Water and rinse | Rinse water quality is part of the validated process | Rinse water quality is part of the validated process |
| Monitoring emphasis | Process records and periodic verification | Process records, chemical test strips and periodic verification |
How do the record-keeping expectations differ?
Both expect a record that ties a scope to its reprocessing. Canada puts the emphasis on the reprocessing method and its parameters — which chemical, at what concentration, for how long, and who did it — together with the traceability back to the patient. The US adds a strong emphasis on the device authorisation: the reprocessing method in your policy has to be the one the labelling describes. Where a facility buys a scope that was authorised in one market and reprocesses it using a method from the other, the mismatch is the finding, not the method itself.
How does the high-level disinfection step compare?
Neither jurisdiction lets a clinic choose a chemical independently of the device. The manufacturer validates a method, and the facility follows it. In practice the differences show up in the details: the contact time, the temperature window, the number of rinse steps and the water quality for the final rinse. Canadian provincial policy may add requirements on top, such as a defined test strip use or a defined hold time after disinfection. When a supplier claims a chemical is "accepted in North America", the useful question is which validated method and which jurisdiction the claim refers to.
What about the instrument pre-clean before the scope step?
The general instrument reprocessing sequence — pre-clean at the point of use, mechanical cleaning, rinse, dry, inspect, package and sterilise — is common to both countries, and so is the role of the ultrasonic bath for lume ned or hinged instruments. Where the two differ is the paperwork attached to the sterilizer that supports the process. In Ontario, the RCDSO requires a biological indicator for each sterilizer on every day it is used, that is daily monitoring, not weekly. The weekly baseline is the CDC / AAMI ST79 standard in most US states. A clinic that applies the US weekly habit to an Ontario sterilizer has a documentation gap even if the machine is working.
Which requirements apply to a clinic that operates in both countries?
Apply the stricter of the two at each site, and keep two documents: one for the Canadian site that names the provincial requirement and the Canadian standard, and one for the US site that names the federal authorisation and the CDC and society guidance. Do not run one blended policy, because a blended policy cannot be pointed at either regulator. Then align the consumables so the same validated method is used at both sites wherever the manufacturer allows it, which reduces training and stock complexity.
What should be verified before writing the policy?
Three things: the reprocessing instructions that came with each scope, the current provincial or state requirement for your site, and the chemical supplier’s validated method statement. Write the policy around those three sources, date it, and review it when a device is replaced. A policy that cites a source by name and date is one you can defend; one that cites habit is not.
Make it repeatable: print the compliance log templates, use the same page as your free log generator, and ask a compliance specialist when a result is unclear.
Ordering for a clinic, lab or care home? Wholesale and multi-site ordering covers case pricing and account setup, and the B2B wholesale collection lists the lines stocked for institutional buyers. Reselling? become a distributor.
Related reading
Single-use vs reusable instruments: cost and compliance · Provincial autoclave monitoring: Ontario vs BC vs Alberta · Sterilization compliance hub
Frequently Asked Questions
Do Canadian and US endoscope reprocessing rules differ?
They use different frameworks. Canada relies on a national reusable-device reprocessing standard with provincial policy; the US relies on federal device authorisation plus CDC and professional society guidance.
Which requirements apply if a clinic operates in both countries?
Apply the stricter requirement at each site and keep a separate policy document for each jurisdiction rather than a blended one.
What record must a Canadian facility keep for each scope?
A reprocessing record per scope and cycle naming the chemical, concentration, contact time and operator, with traceability back to the patient.
Is weekly sterilizer monitoring acceptable in Ontario?
No. In Ontario the RCDSO requires a biological indicator for each sterilizer on every day it is used, which is daily monitoring.
CliniEco Medical is a licensed medical device establishment (MDEL #35334).
0 commentaire